Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
What this means for MEDVi MEDVi continues to offer compounded tirzepatide as of the time of this writing
Este agonista dual de los receptores GIP y GLP-1 est aprobado por la FDA para el tratamiento de la diabetes tipo 2 y el manejo del peso corporal en adultos
Compared to other tirzepatide providers and telehealth platforms: Hims: Offers brand-name Zepbound at $1,899 per month, with compounded options starting lower on prepaid multi-month plans Ro: Brand-name Zepbound vials from $299 to $449 per month for medication plus a $145 per month membership fee Empower Pharmacy (direct): Compounded tirzepatide at varying prices depending on the prescriber Strive Pharmacy : Another compounding option with different pricing structures IVIM falls in the mid-range for compounded tirzepatide telehealth programs
OnayBesikci A, zkan S
In consultation with Dr Kirkham, he will assess your condition, taking into consideration your symptoms and lifestyle
US$ 20.90
US$ 27.48
US$ 20.32
US$ 26.92
